Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-010198
Filing Date
2025-03-31
Accepted
2025-03-31 16:16:09
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K allr20241231_10k.htm   iXBRL 10-K 2879846
2 EXHIBIT 10.74 ex_796257.htm EX-10.74 20516
3 EXHIBIT 19 ex_796562.htm EX-19 69106
4 EXHIBIT 31.1 ex_754416.htm EX-31.1 13037
5 EXHIBIT 31.2 ex_754417.htm EX-31.2 13023
6 EXHIBIT 32.1 ex_754418.htm EX-32.1 5694
7 EXHIBIT 32.2 ex_754419.htm EX-32.2 5681
  Complete submission text file 0001437749-25-010198.txt   11464506

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA allr-20241231.xsd EX-101.SCH 92678
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE allr-20241231_cal.xml EX-101.CAL 53964
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20241231_def.xml EX-101.DEF 625174
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20241231_lab.xml EX-101.LAB 509527
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20241231_pre.xml EX-101.PRE 669449
97 EXTRACTED XBRL INSTANCE DOCUMENT allr20241231_10k_htm.xml XML 1716209
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41160 | Film No.: 25793478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)